Christoph Stephan | Infektiologie | Best Research Article Award

Published on by Cognitive Scientist Awards

Prof. Christoph Stephan | Infektiologie | Best Research Article Award

Universitätsklinik Frankfurt | Germany

Professor Christoph Stephan is a distinguished physician and academic leader in internal medicine and infectious diseases at University Hospital Frankfurt, Goethe University. He serves as the lead physician of the HIVCENTER, the largest university-based outpatient clinic for individuals living with HIV, and has coordinated numerous clinical trials as principal investigator. Renowned for his expertise in HIV pharmacotherapy, management of opportunistic infections, and antimicrobial stewardship, he combines clinical excellence with groundbreaking research. Stephan is an active member of national and international infectious disease societies and has contributed significantly to guideline development programs and educational initiatives. With extensive teaching, mentoring, and publication experience, he has shaped the careers of numerous healthcare professionals. His scholarly work demonstrates a commitment to advancing understanding of HIV and infectious diseases, optimizing patient care, and fostering collaboration between clinical practice and scientific research, establishing him as a global authority in his field.

Profile

ORCID

Education

Professor Stephan completed rigorous medical training and specialized education in internal medicine and infectious diseases, acquiring extensive knowledge of clinical care, pharmacotherapy, and diagnostic methods. His advanced studies included intensive coursework and practical rotations in infectious disease management, HIV care, and treatment of opportunistic infections. Through formal medical education, professional certification, and continuous clinical training, he developed expertise in patient-centered care, evidence-based practice, and research methodology. Stephan’s education also encompassed advanced learning in antimicrobial stewardship, clinical trials management, and guideline development. Complementing his medical degree, he participated in workshops, seminars, and professional development programs focused on HIV medicine, virology, immunology, and healthcare innovation. His education laid the foundation for academic and clinical excellence, enabling him to contribute to national and international scientific communities, mentor emerging professionals, and develop comprehensive care strategies for complex infectious diseases. His dedication to lifelong learning has strengthened his role as both a clinician and a researcher of global standing.

Experience

Professor Stephan has extensive experience as a senior physician and infectious disease specialist at University Hospital Frankfurt, Goethe University. He leads the HIVCENTER, providing comprehensive care to people living with HIV, and oversees numerous outpatient programs and clinical services. As a principal investigator in multiple clinical trials, he has coordinated interdisciplinary teams, managed research protocols, and contributed to scientific advancements in HIV pharmacotherapy and infectious disease treatment. Stephan has significant teaching and mentoring experience, guiding medical students, residents, and early-career researchers in clinical practice, research methodology, and patient care. He actively participates in the development of national and international guidelines, committees, and educational initiatives for infectious diseases. His experience spans clinical practice, research, publication, and policy development, demonstrating leadership, innovation, and commitment to healthcare excellence. Through his work, he has enhanced patient outcomes, advanced scientific knowledge, and strengthened the integration of research and practice in infectious disease management.

Awards and Honors

Professor Christoph Stephan has received recognition for his outstanding contributions to infectious disease research, HIV care, and medical education. He is widely respected for his leadership in clinical trials, scientific publications, and guideline development programs, earning acclaim from national and international professional societies. Stephan’s expertise in HIV medicine, antimicrobial stewardship, and treatment of opportunistic infections has been acknowledged through appointments to advisory boards, leadership roles in professional organizations, and invitations to speak at prestigious conferences. His scholarly achievements, including authorship of numerous textbook chapters and peer-reviewed publications, have further established him as a thought leader in the field. Awards and honors reflect his dedication to improving patient care, advancing medical science, and mentoring future generations of clinicians and researchers. Through recognition from professional associations, academic institutions, and research communities, Stephan’s contributions continue to inspire excellence in the practice and study of infectious diseases and HIV medicine worldwide.

Research Focus

Professor Stephan’s research centers on HIV pharmacotherapy, treatment of opportunistic infections, and antimicrobial stewardship. His work investigates the optimization of antiretroviral therapy, mechanisms of HIV resistance, and strategies to prevent and manage secondary infections in immunocompromised patients. Stephan also explores the clinical and virological outcomes of novel treatment regimens, contributing to evidence-based approaches that improve patient health and quality of life. He is deeply involved in clinical trials, evaluating the safety, efficacy, and long-term impacts of antiviral therapies. His research encompasses guideline development, translational studies, and the integration of clinical findings into routine patient care. By combining rigorous scientific inquiry with practical healthcare applications, Stephan advances understanding of HIV pathophysiology, treatment challenges, and therapeutic innovations. He collaborates with national and international research networks, contributing to multicenter studies, publications, and knowledge dissemination. His work aims to enhance treatment strategies, support personalized medicine, and improve global standards of care for people living with HIV.

 

Publications

 

Title: Clinical Epidemiology of Cancer in People Living with HIV in Germany: A Retrospective, Observational, Multicenter, Federated Claims Data Analysis
Year: 2025

Title: Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final 24‐month results from the prospective German TAFNES cohort study
Year: 2025

Title: Antiretroviral treatment in PLWH with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: a real-world cohort analysis
Year: 2024

Title: Care interruptions and mortality among adults in Europe and North America
Year: 2024

Title: Coinfections and antimicrobial treatment in a cohort of falciparum malaria in a non-endemic country: a 10-year experience
Year: 2024

Title: Differences in the Course of CD4 and CD8 Cells After Chemoradiotherapy in People Living with HIV with Anal Cancer
Year: 2024

Title: HIV treatment with maraviroc: forgotten, not needed or still useful? Results from the MIRROR study
Year: 2024

Conclusion

Professor Christoph Stephan exemplifies excellence in clinical practice, research, and education in infectious diseases and HIV medicine, combining innovative research with compassionate patient care, impactful teaching, and leadership in guideline development, advancing global healthcare standards, improving patient outcomes, and inspiring the next generation of clinicians and researchers.

Prakash Ghosh | Bacteriology | Best Researcher Award

Published on by Cognitive Scientist Awards

Mr. Prakash Ghosh | Bacteriology | Best Researcher Award

University of Leipzig | Germany

Prakash Ghosh is a dedicated researcher and PhD student at the Technische Universität Berlin, working under the supervision of Professor Dr. Martin Siegel, Junior Professor for Empirical Health Economics. His doctoral research focuses on developing evidence-based frameworks for real-time antimicrobial resistance (AMR) monitoring and shaping policy guidelines for implementation within public health systems in low- and middle-income countries (LMICs). With a strong background in biochemistry, molecular biology, and public health, he brings extensive experience in infectious disease research and diagnostic innovation. Previously, he held research and scientific positions at icddr,b and the Infectious Disease Research Institute in Seattle, where he contributed to advancements in molecular diagnostics, vaccine science, and parasitology. Prakash has published widely in peer-reviewed journals and actively reviews manuscripts for reputed international journals. His career is marked by an enduring commitment to addressing global health challenges through translational research, diagnostics, and evidence-based health policies.

Profile

ORCID 

Googlescholar

Education

Prakash Ghosh pursued his academic journey with a strong foundation in life sciences and specialized training in vaccinology and diagnostics. He earned his Bachelor of Science (Honors) in Biochemistry and Molecular Biology from the University of Dhaka, where he developed expertise in fundamental biomedical sciences. He further strengthened his academic credentials with a Master of Science in Biochemistry and Molecular Biology from the same institution, focusing on advanced molecular biology, biochemical processes, and their clinical applications. To enhance his professional competence in vaccine development, Prakash completed a diploma in Vaccinology at the prestigious Pasteur Institute, Paris, France. This training equipped him with a deeper understanding of immunization strategies and translational vaccine science. His multidisciplinary education has laid the foundation for his research career in infectious diseases, diagnostics, and public health interventions. Currently, as a doctoral candidate at Technische Universität Berlin, he integrates his educational background with health economics and global health policy.

Experience

Prakash Ghosh has over a decade of experience in biomedical research and infectious disease studies, with significant contributions to diagnostics and global health. He began his career as a Research Fellow in the Parasitology Laboratory at icddr,b, advancing through roles as Research Officer, Senior Research Officer, and Research Investigator in the Emerging Infections and Parasitology Laboratory. His work primarily focused on parasitic infections, serological and molecular diagnostics, and public health challenges in endemic regions. He further broadened his expertise as a Visiting Scientist at the Infectious Disease Research Institute, Seattle, where he contributed to formulation and translational research on infectious diseases. Currently, he serves as an Assistant Scientist at icddr,b, leading projects on emerging infections and innovative diagnostic strategies. His career demonstrates a strong trajectory of research leadership, capacity building, and international collaboration, with a commitment to developing tools and strategies that strengthen healthcare systems in LMICs.

Awards and Honors

Prakash Ghosh has been recognized with several prestigious fellowships and awards for his contributions to infectious disease research and diagnostics. He received the ESCMID Fellowship for advanced training in antimicrobial stewardship and diagnostics in Germany.  He was awarded the ACDx Fellowship from Fondation Mérieux, France, for his innovative work in applied diagnostics. His outstanding contributions to global health were also acknowledged with the IP Fellowship from the Pasteur Institute, Paris, providing him an opportunity to deepen his expertise in vaccinology. Additionally, he was honored with the WHO-TDR Clinical Research and Development Fellowship , which allowed him to gain critical insights into clinical research practices and implementation in resource-limited settings. These accolades reflect his dedication to bridging laboratory research and public health policy, as well as his growing recognition as an emerging leader in infectious diseases, diagnostics, and global health policy

Research Focus

Prakash Ghosh’s research lies at the intersection of infectious disease diagnostics, vaccine science, and health policy. His primary focus is on developing cost-effective, scalable, and evidence-based diagnostic tools for infectious diseases, particularly in low- and middle-income countries (LMICs). He has worked extensively on molecular and serological diagnostics for parasitic diseases, viral infections, and antimicrobial resistance, contributing to global efforts in disease elimination and control. His research extends to health economic analyses, with the aim of informing policymakers on the affordability and sustainability of diagnostic interventions. Prakash is also engaged in translational vaccine science, exploring innovative solutions to strengthen immunization programs in resource-constrained environments. His doctoral research at Technische Universität Berlin emphasizes real-time monitoring of antimicrobial resistance and its integration into LMIC public health systems. By combining bench science with economic evaluation and implementation research, he aspires to influence global strategies that address emerging infectious disease challenges.

Publications

Title: Quantifying the infectiousness of post-kala-azar dermal leishmaniasis toward sand flies
Year: 2019
Citation: 143

Title: Mobile suitcase laboratory for rapid detection of Leishmania donovani using recombinase polymerase amplification assay
Year: 2016
Citation: 129

Title: Bacteriophages isolated from stunted children can regulate gut bacterial communities in an age-specific manner
Year: 2020
Citation: 128

Title: Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to …
Year: 2017
Citation: 103

Conclusion

Prakash Ghosh is a globally engaged researcher dedicated to advancing infectious disease diagnostics, antimicrobial resistance monitoring, and vaccine science, with a strong focus on LMIC public health systems, combining laboratory innovation, health economics, and translational research to drive evidence-based global health policies.